Literature DB >> 15618940

Integrated treatment of co-occurring mental illness and addiction: clinical intervention, program, and system perspectives.

Douglas M Ziedonis1.   

Abstract

Individuals with mental illness and addiction comprise at least half of the patients in most mental health treatment systems. This combination results in increased risk for frequent psychiatric relapses, poor medication compliance, violence, suicide, legal problems, and high utilization of the emergency room or inpatient services. Traditional mental health and addiction treatments have not adequately addressed these co-occurring disorders due to clinical interventions, programs, and system flaws that have not addressed the individual's needs. Integrated treatment requires both an understanding of mental illness and addiction and the means to integrate and modify the traditional treatment approaches in both the mental health and addiction treatment fields. There is strong evidence to support the efficacy and effectiveness of integrated treatment in this population. All mental health clinicians should become experienced and skilled in the core psychotherapy approaches to treating substance use disorders, including motivational enhancement therapy, relapse prevention (cognitive-behavioral therapy), and 12-step facilitation. In addition, integrated treatment includes integrating medications for both addiction and mental illness with the behavioral therapies and other psychosocial interventions. This article reviews the clinical intervention, program, and system components of integrated treatment and specific clinical interventions for this population.

Entities:  

Mesh:

Year:  2004        PMID: 15618940     DOI: 10.1017/s1092852900009718

Source DB:  PubMed          Journal:  CNS Spectr        ISSN: 1092-8529            Impact factor:   3.790


  22 in total

Review 1.  Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?

Authors:  Mark J Niciu; Ioline D Henter; Gerard Sanacora; Carlos A Zarate
Journal:  World J Biol Psychiatry       Date:  2013-09-12       Impact factor: 4.132

2.  Adapting problem-solving therapy for depressed older adults in methadone maintenance treatment.

Authors:  Daniel Rosen; Jennifer Q Morse; Charles F Reynolds
Journal:  J Subst Abuse Treat       Date:  2010-10-30

3.  Drug use, drug severity, and help-seeking behaviors of lesbian and bisexual women.

Authors:  Heather L Corliss; Christine E Grella; Vickie M Mays; Susan D Cochran
Journal:  J Womens Health (Larchmt)       Date:  2006-06       Impact factor: 2.681

4.  A roadmap to key pharmacologic principles in using antipsychotics.

Authors: 
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

Review 5.  Pharmacological treatment of schizophrenia and co-occurring substance use disorders.

Authors:  David A Smelson; Lisa Dixon; Thomas Craig; Stephen Remolina; Steven L Batki; Noosha Niv; Richard Owen
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

6.  Classifying substance use disorder treatment facilities with co-located mental health services: A latent class analysis approach.

Authors:  Pia M Mauro; C Debra Furr-Holden; Eric C Strain; Rosa M Crum; Ramin Mojtabai
Journal:  Drug Alcohol Depend       Date:  2016-04-07       Impact factor: 4.492

Review 7.  Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations.

Authors:  Douglas M Ziedonis; David Smelson; Richard N Rosenthal; Steven L Batki; Alan I Green; Renata J Henry; Ivan Montoya; Joseph Parks; Roger D Weiss
Journal:  J Psychiatr Pract       Date:  2005-09       Impact factor: 1.325

8.  Serious mental illness and medical comorbidities: Findings from an integrated health care system.

Authors:  Amber L Bahorik; Derek D Satre; Andrea H Kline-Simon; Constance M Weisner; Cynthia I Campbell
Journal:  J Psychosom Res       Date:  2017-07-08       Impact factor: 3.006

9.  Chronic Disease Screening and Prevention Activities in Mental Health Clinics in New York State: Current Practices and Future Opportunities.

Authors:  Michael T Compton; Marc W Manseau; Heather Dacus; Barbara Wallace; Michael Seserman
Journal:  Community Ment Health J       Date:  2020-01-04

10.  The associations between substance use disorders, schizophrenia-spectrum disorders, and Axis IV psychosocial problems.

Authors:  Michael T Compton; Paul S Weiss; Joyce C West; Nadine J Kaslow
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2005-10-25       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.